Pregabalin add-on for drug-resistant partial epilepsy

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2008, Pages

  Lozsadi, Dora ^a   Hemming, K ^b   Marson, A G ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE ACETATE; POLY(METHYL METHACRYLATE); POLYACRYLONITRILE; POLYAMIDE; POLYSULFONE;

ACUTE KIDNEY FAILURE; BIOCOMPATIBILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIALYSIS MEMBRANE; HUMAN; KIDNEY FUNCTION; META ANALYSIS; MORTALITY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW;

EID: 44949102287     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005612.pub2     Document Type: Review

References (13)

1. Arroyo 2004 {published and unpublished data} Arroyo S, Anhut H, Kugler AR, Lee CM, Knapp LE, Garofalo EA, et al.Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 2004;45(1):20-7.
2. Beydoun 2005 {published and unpublished data} *Beydoun A, Uthman BM, Kugler AR, Greiner MJ, Knapp LE, Garofalo EA, Pregabalin 1008-009 Study Group. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 2005;64(3): 475-80.
3. Elger 2005 {published and unpublished data} Elger CE, Brodie MJ, Anhut H, Lee CM, Barrett JA. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study. Epilepsia 2005;46(12):1926-36.
4. French 2003 {published and unpublished data} French JA, Kugler AR, Robbins JL, Knapp LE, Garofalo EA. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 2003;60(10):1631-7.
5. Brodie 2005 Brodie MJ, Wilson EA, Wesche DL, Alvey CW, Randinitis EJ, Posvar EL, et al.Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy. Epilepsia 2005;46:1407-13.
6. Cockerell 1995 Cockerell OC, Johnson AL, Sander JW, Hart YM, Shorvon SD. Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet 1995;346(8968):140-4.
7. Elbourne 2002 Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
8. Fink 2002 Fink K, Dooley DJ, Meder WP, Suman-Chauhan N, Duffy S, Clusmann H, et al.Inhibition of neuronal (Ca 2+) influx by gabapentin and pregabalin in human neocortex. Neuropharmacology 2002;42(2):229- 36.
9. Hauser 1983 Hauser WA, Annegers JF, Anderson VE. Epidemiology and the genetics of epilepsy. In: WardAA, et al. editor(s). Epilepsy. New York: Raven Press, 1983:274.
10. Higgins 2005 Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.4 [updated March 2005]. Cochrane Database of Systematic Reviews 2005, Issue 2.
11. ILAE Commission Commission on Antiepileptic Drugs of the International League Against Epilepsy. Guidelines for clinical evaluation of antiepileptic drugs. Epilepsia 1989;30(4):400-8.
12. McCullagh 1989 McCullagh P, Nelder JA. Generalized Linear Models. 2nd Edition. London: Chapman & Hall, 1989.
13. Villeneuve 2004 Villeneuve N. [Quality-of-life scales for patients with drug-resistant partial epilepsy]. Reviews of Neurology (Paris) 2004;160(Spec No.1):5S376-93.